PIK3CA Mutational Status Assessment
NCT06706570 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-03-24
Summary
Evaluation of PIK3CA mutational status: a route towards a tailored diagnostic approach.
Conditions
- Breast Cancer Metastatic
Sponsors & Collaborators
-
European Institute of Oncology
lead OTHER
Principal Investigators
-
Nicola Fusco, MD · Istituto Europeo di Oncologia
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-06
- Primary Completion
- 2026-12-31
- Completion
- 2030-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC
NCT04480814 ·Status: COMPLETED
-
Discordant HER2/Neu Status of Breast Cancer.
NCT01935739 ·Status: COMPLETED
-
Safety of Pregnancy in BRCA Mutated Breast Cancer Patients
NCT03673306 ·Status: COMPLETED
-
Integrated Testing Strategy for Simultaneous Detection of ESR-1 and gBRCA Mutations Via Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer (mBC) Patients,
NCT06762483 ·Status: RECRUITING
-
Breast Cancer Detection in Breast Surgical Specimens With the Histolog Scanner, Slide-free Confocal Microscope
NCT04976556 ·Status: COMPLETED
-
Improving the Approach to and Management of the Older Metastatic Breast Cancer Patient
NCT03007641 ·Status: COMPLETED ·Phase: NA
-
Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone
NCT06321666 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis Modality
NCT01024114 ·Status: WITHDRAWN
-
Prospective Observational Study for Breast Microcalcifications' Classification With Artificial Intelligence Techniques
NCT05767424 ·Status: ACTIVE_NOT_RECRUITING
-
MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer
NCT06247449 ·Status: RECRUITING ·Phase: NA
-
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study
NCT00006425 ·Status: COMPLETED
-
Prevalence of Emerging Treatment-induced Mutations in Metastatic ER-positive Breast Cancer.
NCT06417801 ·Status: RECRUITING
-
Study of Metabolites Markers in Adjuvant Breast Cancer
NCT03367208 ·Status: COMPLETED
-
Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas
NCT06805084 ·Status: ACTIVE_NOT_RECRUITING
-
Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI
NCT03709186 ·Status: COMPLETED
-
Imaging the Patterns of Breast Cancer Early Metastases
NCT02706964 ·Status: COMPLETED ·Phase: NA
-
Breast Cancer and Its Relationship With the Microbiota
NCT03885648 ·Status: ACTIVE_NOT_RECRUITING
-
Discordant Hormonal Status of Breast Cancer.
NCT01943032 ·Status: COMPLETED
-
Sensitivity of Organoids to Predict Treatment Outcome in Breast Cancer Metastases
NCT06468124 ·Status: RECRUITING
-
Identification of Novel Genetic Factors That Contribute to Risk for Breast Cancer
NCT00276120 ·Status: COMPLETED
-
Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS
NCT02766881 ·Status: COMPLETED
-
Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer
NCT06790264 ·Status: RECRUITING ·Phase: NA
-
Study Investigating the Role of Routine Screening and Molecular Characterisation of Brain Metastasis in the Management of High-risk Metastatic Breast Cancer
NCT06728150 ·Status: NOT_YET_RECRUITING
-
Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer
NCT01460186 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Prognostic Monitoring for Young Breast Cancer Patients
NCT04145986 ·Status: UNKNOWN